• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

A型肉毒杆菌毒素治疗雷诺综合征:一例报告

Botulinum Toxin Type A in the Treatment of Raynaud's Syndrome: A Case Report.

作者信息

Penchev Plamen, Dobrev Valentin, Petrov Petar-Preslav, Hyusein Remzi, Velchev Vladislav, Georgiev Kristiyan

机构信息

Faculty of Medicine, Medical University of Plovdiv, Plovdiv, BGR.

Department of Neurology, Medical Center "VIP", Targovishte, BGR.

出版信息

Cureus. 2024 Mar 31;16(3):e57327. doi: 10.7759/cureus.57327. eCollection 2024 Mar.

DOI:10.7759/cureus.57327
PMID:38690447
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11060183/
Abstract

Raynaud's syndrome is characterized by paroxysmal vasospasm in the digital arterioles, following exposure to cold or stress. Pain, swelling, stiffness, and hypoesthesia are observed as manifestations. The presence of a trophic ulcer is accompanied by a range of severe manifestations. The assaults occur in three distinct phases, namely vasospastic, plethoric, and erythema. Various approaches improve the overall well-being of a patient. It is possible to differentiate between primary and secondary Raynaud's syndrome, the latter being linked to systemic diseases. The application of botulin toxin is commonly indicated in several medical conditions including focal dystonia, spasticity with or without contractures, paraparesis in children with cerebral palsy, multiple sclerosis, brain injuries, involuntary muscle hyperactivity of a non-dystonic nature, pain management, strabismus, nystagmus, sialorrhea, and esthetic medicine. When treating Raynaud's a technique is used with injection at the base of each finger, from the palmar side, which helps with cooling and minimizing discomfort for patients. We present a clinical case of a 70-year-old female patient with Raynaud's syndrome in which we have placed 70E distributed to both hands botulin toxin type A. Improvement in the patient's symptomatology was noticed on day 3, with warming of the hands, lack of swelling, and pain with duration of the effect little over three months. The patient underwent a six-month follow-up following the therapy with botulinum toxin type A, and no indications of recurrence or advancement of Raynaud's syndrome (RS) were seen.

摘要

雷诺综合征的特征是在接触寒冷或压力后,手指小动脉出现阵发性血管痉挛。疼痛、肿胀、僵硬和感觉减退是其表现。营养性溃疡的出现伴有一系列严重表现。发作分为三个不同阶段,即血管痉挛期、充血期和红斑期。多种方法可改善患者的整体健康状况。原发性和继发性雷诺综合征可以区分,后者与全身性疾病有关。肉毒毒素在多种医疗状况中普遍适用,包括局限性肌张力障碍、伴有或不伴有挛缩的痉挛、脑瘫儿童的截瘫、多发性硬化症、脑损伤、非肌张力障碍性的不自主肌肉活动亢进、疼痛管理、斜视、眼球震颤、流涎以及美容医学。治疗雷诺综合征时,采用从手掌侧在每个手指根部注射的技术,这有助于患者手部保暖并减轻不适。我们呈现了一例70岁女性雷诺综合征患者的临床病例,我们向其双手注射了70E单位的A型肉毒毒素。在第3天观察到患者症状有所改善,手部变暖,肿胀消失,疼痛缓解,效果持续略超过三个月。患者在接受A型肉毒毒素治疗后进行了为期六个月的随访,未发现雷诺综合征复发或进展的迹象。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/86ad/11060183/fcc5aea46bf1/cureus-0016-00000057327-i02.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/86ad/11060183/68d180fbb8c2/cureus-0016-00000057327-i01.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/86ad/11060183/fcc5aea46bf1/cureus-0016-00000057327-i02.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/86ad/11060183/68d180fbb8c2/cureus-0016-00000057327-i01.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/86ad/11060183/fcc5aea46bf1/cureus-0016-00000057327-i02.jpg

相似文献

1
Botulinum Toxin Type A in the Treatment of Raynaud's Syndrome: A Case Report.A型肉毒杆菌毒素治疗雷诺综合征:一例报告
Cureus. 2024 Mar 31;16(3):e57327. doi: 10.7759/cureus.57327. eCollection 2024 Mar.
2
[Botulinum toxin type A contribution in the treatment of Raynaud's phenomenon due to systemic sclerosis].[A型肉毒杆菌毒素在治疗系统性硬化症所致雷诺现象中的作用]
Ann Chir Plast Esthet. 2013 Dec;58(6):658-62. doi: 10.1016/j.anplas.2011.11.001. Epub 2011 Dec 26.
3
Targeted high concentration botulinum toxin A injections in patients with Raynaud's phenomenon: a retrospective single-centre experience.靶向高浓度肉毒毒素 A 注射治疗雷诺现象患者:单中心回顾性经验。
Rheumatol Int. 2021 May;41(5):943-949. doi: 10.1007/s00296-020-04606-4. Epub 2020 May 23.
4
Evaluation of Botulinum Toxin Type A and its Potential Effect on Exacerbated Raynaud's Phenomenon in Hospitalized Scleroderma Patients.评价 A 型肉毒毒素及其对住院硬皮病患者雷诺现象恶化的潜在影响。
Curr Rheumatol Rev. 2022;18(1):48-57. doi: 10.2174/1573397117666211012105611.
5
Botulinum toxin A treatment of Raynaud's phenomenon: a review.肉毒杆菌毒素 A 治疗雷诺现象:综述。
Semin Arthritis Rheum. 2012 Feb;41(4):599-603. doi: 10.1016/j.semarthrit.2011.07.006. Epub 2011 Aug 24.
6
Optimisation of botulinum toxin type a treatment for the management of Raynaud's phenomenon using a dorsal approach: a prospective case series.采用背侧入路优化 A 型肉毒毒素治疗雷诺现象:一项前瞻性病例系列研究。
Clin Rheumatol. 2019 Dec;38(12):3669-3676. doi: 10.1007/s10067-019-04762-4. Epub 2019 Sep 3.
7
Is axillary botulinum toxin efficient in controlling secondary Raynaud's phenomenon? A case report.腋窝注射肉毒杆菌毒素对控制继发性雷诺现象是否有效?一例病例报告。
J Scleroderma Relat Disord. 2021 Oct;6(3):327-329. doi: 10.1177/23971983211034077. Epub 2021 Jul 29.
8
Efficacy of botulinum toxin type A injection for Raynaud's phenomenon and digital ulcers in patients with systemic sclerosis.A型肉毒杆菌毒素注射治疗系统性硬化症患者雷诺现象和指端溃疡的疗效
Reumatologia. 2022;60(6):392-398. doi: 10.5114/reum.2022.120757. Epub 2022 Dec 30.
9
Botulinum toxin type A in the treatment of Raynaud's phenomenon.A型肉毒杆菌毒素治疗雷诺现象。
Dermatol Ther. 2020 Nov;33(6):e14182. doi: 10.1111/dth.14182. Epub 2020 Sep 10.
10
Botulinum toxin type A in the treatment of Raynaud's phenomenon: A three-year follow-up study.A型肉毒杆菌毒素治疗雷诺现象:一项为期三年的随访研究。
Eur J Rheumatol. 2018 Dec;5(4):224-229. doi: 10.5152/eurjrheum.2018.18013. Epub 2018 Oct 12.

本文引用的文献

1
Botulinum toxin type A in the treatment of Raynaud's phenomenon: A three-year follow-up study.A型肉毒杆菌毒素治疗雷诺现象:一项为期三年的随访研究。
Eur J Rheumatol. 2018 Dec;5(4):224-229. doi: 10.5152/eurjrheum.2018.18013. Epub 2018 Oct 12.
2
The novel use of botulinum toxin A for the treatment of Raynaud's phenomenon in the toes.肉毒杆菌毒素A在治疗脚趾雷诺现象中的新用途。
BMJ Case Rep. 2018 Mar 9;2018:bcr-2017-219348. doi: 10.1136/bcr-2017-219348.
3
The Therapeutic Efficacy of Botulinum Toxin in Treating Scleroderma-Associated Raynaud's Phenomenon: A Randomized, Double-Blind, Placebo-Controlled Clinical Trial.
肉毒毒素治疗硬皮病相关雷诺现象的疗效:一项随机、双盲、安慰剂对照临床试验。
Arthritis Rheumatol. 2017 Aug;69(8):1661-1669. doi: 10.1002/art.40123. Epub 2017 Jun 26.
4
Beneficial effect of botulinum toxin A on Raynaud's phenomenon in Japanese patients with systemic sclerosis: A prospective, case series study.A型肉毒杆菌毒素对日本系统性硬化症患者雷诺现象的有益作用:一项前瞻性病例系列研究。
J Dermatol. 2016 Jan;43(1):56-62. doi: 10.1111/1346-8138.13030. Epub 2015 Jul 15.
5
A prospective study of the use of botulinum toxin injections in the treatment of Raynaud's syndrome associated with scleroderma.一项关于肉毒杆菌毒素注射治疗硬皮病相关雷诺综合征的前瞻性研究。
J Hand Surg Eur Vol. 2014 Oct;39(8):876-80. doi: 10.1177/1753193413516242. Epub 2013 Dec 24.
6
[Botulinum toxin type A contribution in the treatment of Raynaud's phenomenon due to systemic sclerosis].[A型肉毒杆菌毒素在治疗系统性硬化症所致雷诺现象中的作用]
Ann Chir Plast Esthet. 2013 Dec;58(6):658-62. doi: 10.1016/j.anplas.2011.11.001. Epub 2011 Dec 26.
7
Botulinum toxin A treatment of Raynaud's phenomenon: a review.肉毒杆菌毒素 A 治疗雷诺现象:综述。
Semin Arthritis Rheum. 2012 Feb;41(4):599-603. doi: 10.1016/j.semarthrit.2011.07.006. Epub 2011 Aug 24.
8
Botulinum toxin type A in the treatment of Raynaud's phenomenon.A型肉毒杆菌毒素治疗雷诺现象。
J Hand Surg Am. 2010 Dec;35(12):2085-92. doi: 10.1016/j.jhsa.2010.09.019.
9
Botulinum toxin type A: a treatment option for digital ischemia in patients with Raynaud's phenomenon.A型肉毒杆菌毒素:雷诺现象患者手指缺血的一种治疗选择。
J Hand Surg Am. 2009 Mar;34(3):446-52. doi: 10.1016/j.jhsa.2008.11.026.
10
Management of vasospastic disorders with botulinum toxin A.用A型肉毒毒素治疗血管痉挛性疾病
Plast Reconstr Surg. 2007 Jan;119(1):217-226. doi: 10.1097/01.prs.0000244860.00674.57.